logo
logo

Javara Secures Significant Strategic Growth Investment From General Atlantic

Apr 12, 2022•over 3 years ago
Winston-Salem

Description

Javara, a leading integrated research organization (IRO) and a pioneer of clinical research as a care option (CRAACO), today announced it has secured a significant strategic growth investment in Series B funding from global growth equity firm General Atlantic. Established in 2018 by Jennifer Byrne, CEO, Amanda Wright, CDO and Linda McCarty, General Counsel and Privacy Officer, Javara was built with a vision to revolutionize the industry by accelerating access to research – for patients, biopharma companies and healthcare organizations alike.

Company Information

Company

Javara

Location

Winston-Salem, North Carolina, United States

About

Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. Our access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.